About Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
Clinical Trials at Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
During the past decade, Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie"
#1 collaborator was "Deutsche Krebshilfe e.V., Bonn (Germany)" with 2 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
According to Clinical.Site data, the most researched conditions in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie" are
"Acute Lymphoblastic Leukemia, Pediatric" (1 trials), "B-cell Lymphoma" (1 trials), "Leukemia" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
Most popular intervention types in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie" are "Drug" (4 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Doxorubicin" (2 trials), "Rituximab" (2 trials), "Vincristine" (2 trials) and "6-Mercaptopurine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
The vast majority of trials in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie" are
4 trials for "All" genders.
Clinical Trials Status at Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie
Currently, there are NaN active trials in "Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Otto von Guericke Uni Magdeburg Uniklinik; Hämatologie/Onkologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".